UNITEDHEALTH GROUP INC (UNH) Earnings History
UNITEDHEALTH GROUP INC - Q1 2026 EarningsBeat
EXECUTIVE SUMMARY
UnitedHealth Group reported solid first-quarter results, driven by strong performance in UnitedHealthcare and strategic investments in technology and operations. The company raised its full-year earnings outlook, signaling confidence in its ongoing initiatives to simplify healthcare and enhance value.
POSITIVE HIGHLIGHTS
- •
Consolidated revenues grew 2% year-over-year to $111.7 billion.
positive - •
Raised full year 2026 earnings outlook to greater than $17.35 per share (GAAP) and greater than $18.25 per share (Adjusted).
positive - •
UnitedHealthcare operating margin expanded 40 basis points to 6.6%.
positive - •
Cash flows from operations were $8.9 billion, 1.4x net income, indicating strong cash generation.
positive
CONCERNS & RISKS
- •
Operating cost ratio increased to 13.8% from 12.4% in the prior year, reflecting significant investments in people, processes, and technology.
attention - •
UnitedHealthcare served 49.1 million people, a decrease from 49.8 million at year-end 2025, with declines in Medicare Advantage and Medicaid.
attention - •
Optum Health revenues decreased 3% year-over-year to $24.1 billion, reflecting fewer value-based care members.
negative - •
Optum Health operating earnings decreased year-over-year, impacted by continued investments and elevated medical costs.
attention - •
Days claims payable increased sequentially to 48.6 from 44.1 in Q4 2025, driven by seasonality and claims payment timing.
attention
FINANCIAL METRICS
MARGIN ANALYSIS
Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
REVENUE BY SEGMENT — Q1 2026 2026
VISUAL OVERVIEW
DETAILED BREAKDOWN
| Segment | Current | Prior Yr | YoY | % Total |
|---|---|---|---|---|
UnitedHealthcare | N/A | — | — | — |
Optum | N/A | — | — | — |
| Total Revenue | $0.00M | — | — | 100.0% |
Segment performance shows business unit health and growth drivers.
MANAGEMENT GUIDANCE
FY2026
Forward-looking guidance is subject to change and does not constitute a guarantee. Actual results may differ materially from these estimates.
EARNINGS CALL —
CALL GUIDANCE — Q1 2026 2026
| Metric | Value | Period | Specificity | vs Prior |
|---|---|---|---|---|
| ai_related_initiatives_investment | nearly 1.5 billion | 2026 | point | New |
| total_membership_decline | approximately 1/3 | 2026 | directional | New |
| medical_prior_authorizations_reduction | 30% or more | by the end of this year | directional | New |
| optum_health_margin | 6 to 8% | long-term | tight_range | New |
| fee_for_service_standards_adoption | nearly 80% | by the end of the second quarter | point | New |
| adjusted_earnings_per_share | greater than $18.25 | fullear outlook | directional | New |
| share_repurchases_deployment | at least 2 billion | by the end of the second quarter | directional | New |
| medicare_advantage_margin_advance | 50 basis point year-over-year | 2026 | point | New |
| medicare_advantage_margin | upper half of the 2 to 4% long-term range | 2027 | directional | New |
| ai_investment_return | 2 is to one | over the next few years | point | New |
| ai_programs_payback_period | 12 to 18 months | next 12 to 18 months | tight_range | New |
| prior_authorization_approval_rate | 96% | this quarter | point | New |
| optimal_transactions | over two and a half billion | end of the year | directional | New |
| share_repurchases_deployment | 2.5 billion | original guidance | point | New |
CAPITAL ALLOCATION — Q1 2026 2026
- liquiditycontinue
$1.8 billion · quarter end
- buybackcontinue
$450 million · second quarter
- authorizationreaffirm
$1.1 billion · through December 31, 2026
- capex_policycontinue
$1.5 billion · in 2026
- divestmentnew
$525 million · funded by sale of our UK business
- dividendnew
$400 million · funded by net proceeds from UK business sale
- buybackaccelerate
at least $2 billion · by the end of the second quarter · funded by cash flow performance
- deleveragingtarget
40% · year-end · debt to capital ratio: 40%
- m_and_a_fundingnew
funded by Optum Financial Services
- buybackcontinue
approximately $2.5 billion · back halfloaded
MACRO STANCE — Q1 2026 2026
- inflationheadwindnew
- demand_environmentheadwindnew
- ratesheadwindnew
Q&A SIGNALS — Q1 2026 2026
SPECIAL ITEMS & ADJUSTMENTS
Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.
MANAGEMENT COMMENTARY
Continuing to help simplify and modernize health care for the people and care providers we serve, bringing greater value, affordability, transparency and connectivity.
The company expects full year 2026 adjusted net earnings of greater than $18.25 per share.
The company continues to build on the initiatives begun in the second half of 2025, strengthening in essential areas including operations, management, technology, consumer and provider experiences, community engagement and corporate governance.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
OPERATIONAL METRICS
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.